Ameritas Investment Partners, Inc. Zynerba Pharmaceuticals, Inc. Transaction History

Ameritas Investment Partners, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 05, 2020	SELL	$3.31 - $6.54 $6,073 - $12,000	-1,835 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$5.4 - $15.5 $9,909 - $28,442	1,835 New	1,835 $25,000
Q2 2018 Aug 13, 2018	SELL	$7.98 - $12.39 $7,987 - $12,402	-1,001 Closed	0 $0
Q2 2017 Aug 15, 2017	BUY	N/A	1,001	1,001 $17,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.